13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-02-03 Event 2024-12-30 SEC 0000929638-25-000503 →

Ho Chi Sing CASI Pharmaceuticals, Inc. CASIF

Stake: 6.40% Shares: 992,638 CUSIP: G1933S101 Class: Ordinary Shares, $0.0001 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 29.02
442,451 shares short · -3.4% vs prior

Other Filings by Ho Chi Sing

FiledFormIssuerStakeShares
2018-03-20 SC CASI Pharmaceuticals, Inc. view →
2018-02-13 SC Sky Solar Holdings, Ltd. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →